Good Lifestyle

If you have heard of type 2 diabetes drug Ozempic , it is probably linked to the spectacular results of weight loss that it is known to produce. The medication, officially known as semaglutide, the fact by imitating the peptide-1 hormone of the glucagon type (GLP-1) in the intestine, effectively lowering blood sugar levels and blood sugar levels and blood levels and blood sugar levels and levels of blood sugar and blood levels decrease . With this approach, Ozempic and his sister drug, Wegovy, changed life for some. But like all weight loss strategies, it is natural to wonder what is happening when you stop treatment. Now, a new investigation by Deutsche Bank responds to a greater concern for those who interrupt GLP-1 drugs like Ozempic: how their eating habits will change.

In relation: Ozempic patients say that "stops working" for weight loss - how to prevent this .

When people start to take GLP -1 drugs like Wegovy and Ozempic - both well -known options made by Novo Nordisk, but far from the only one GLP-1 physicians on the market —Calorie Count decreases, the Investigation found , by CNBC. However, when patients interrupt medication, the number of calories goes up and some patients consume even more calories than before starting treatment.

The bank interviewed 600 American consumers in December 2023, 70% of which took GLP-1 medicines when they responded to the survey. The other 30% had already ceased to take these drugs.

When the patients still under GLP-1 were asked about their eating habits, 30% said they had eaten "a little less" and 22% said they were eating "much less". Also in this group, 17% said they were eating a lot more , while the remaining 18% said they ate a little more. The researchers said that these results were surprising because it had allowed only 18% of those who still GLP-1 eating less than they had before starting the medication.

However, the people who had stopped taking the drug had different answers.

"Among those who no longer took GLP-1, more than inversion with a net of 30% declaring that they now ate more than before using GLP-1 drugs," said the report of the survey , according to CNBC.

Deutsche Bank has executed the survey to better understand how Ozempic and Weogvy, as well as other treatments like Eli Lilly Mounjaro And Zepbound , affect the food and drinks industry. (Mounjaro and Zepbound are the brand names for shooting , which activates the GLP-1 hormone as well as the insulinotropic polypeptide dependent on glucose.)

In relation: What really happens if you stop taking Ozempic, say the doctors .

Regarding the global objective of understanding the actions of food and drinks, the researchers said that they did not think that GLP-1 drugs are "reason in itself to avoid investing". They also added that the effect of these drugs should be assessed "in the context of all weight loss programs and the possibility that GLP-1 cannibalise such programs, limiting the net effect on food producers and of drinks, "reported CNBC. AE0FCC31AE342FD3A1346EBB1F342FCB

Experts told CNBC that the results of the survey were not necessarily surprising, because our body tends to return to a defined weight when we do not intervene with drugs or changing behaviors. But for his part, a spokesperson for Novo Nordisk said Better life These Wegovy clinical trials have in fact shown that patients are gaining weight when they stop taking these medicines - and it is not unexpected.

"This supports the conviction that obesity is a chronic disease that requires long -term care, much like high blood pressure or high cholesterol, for which most patients remain under long -term treatment in order to continue to benefit from the advantages of their drugs ". The declaration is read

Eli Lilly had similar comments on the effectiveness of traditional approaches. In a statement to CNBC, a company spokesperson said: "We know that for some people living with obesity, diet, exercise and / or behavioral advice often fails in the long term, and They need more to achieve their weight goals. "

Better life contacted Eli Lilly to comment, and will update history with his answer.

In relation: For more information, register for our daily newsletter .

Best Life offers the most up -to -date information for high -level experts, new research and health agencies, but our content is not supposed to replace professional advice. Regarding the medication you take or any other health issue you have, always consult your health care provider directly.